Labshake search
Citations for BioLegend :
1901 - 1950 of 3446 citations for Marker 7 Pcb Mixture W Pcb 118 13C12 99% 100 Ng Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2024Quote: ... and APC anti-mouse P2RY12 (S16007D) (1:100) (BioLegend, San Diego, CA). For TMEM119 staining ...
-
BTK and MMP9 regulate NLRP3 inflammasome-dependent cytokine and NET responses in primary neutrophilsbioRxiv - Immunology 2024Quote: ... the cells were fixed with 100 μL of Fixation Buffer 1X (Biolegend) for 10 min at RT ...
-
bioRxiv - Developmental Biology 2024Quote: Single cells were stained with anti-CD31-APC (1:100) (BioLegend; 102510), anti-CD45-APC (1:100 ...
-
Regulation of Diseases-Associated Microglia in the Optic Nerve by Lipoxin B4 and Ocular HypertensionbioRxiv - Molecular Biology 2024Quote: ... Sections were then incubated in primary antibodies (anti-CD74, 1:100, BioLegend; anti-Iba1 ...
-
bioRxiv - Neuroscience 2024Quote: ... Following antibodies were used: FITC anti-mouse CD206 (1:100, #141703, BioLegend), PE anti-mouse NeuN (1:3000 ...
-
bioRxiv - Cancer Biology 2023Quote: ... BV421 anti-I-A/I-E (1:100, M5/114.15.2, Biolegend, 107631). Foxp3 was detected by staining with Alexa Fluor 647 (A647 ...
-
bioRxiv - Cancer Biology 2021Quote: ... Splenocytes were plated in 1,000,000 cells/mL in cRPMI supplemented with 0.5 μg/mL anti-CD3 (Clone 145-2C11, Biolegend), 0.5 μg/mL anti-CD28 (Clone 37.51 ...
-
bioRxiv - Immunology 2021Quote: ... a suspension of 2.5×105 cells/ml was prepared and 2.5 μg/ml of Brefeldin A (Biolegend) and Golgistop (BD Biosciences ...
-
bioRxiv - Immunology 2022Quote: ... or plate-bound α-CD3ε (2 μg/mL) and plate-bound CD155-Fc (1 μg/mL; BioLegend) for four days ...
-
bioRxiv - Immunology 2020Quote: ... or 2) 10 μg/mL αLFA-1 + 10 μg/mL antibodies against CD16 (αCD16; BioLegend, clone 3G8). All loading solutions were mixed in PBS and supplemented with 10 μg/mL bovine serum albumin (BSA ...
-
bioRxiv - Immunology 2022Quote: ... in the presence of rhIL-2 (50U/ml, Novartis) and anti-IFNγ (5µg/ml, clone XMG1.2, Biolegend). For intracellular cytokine staining ...
-
bioRxiv - Cancer Biology 2022Quote: ... were activated with plate-bound anti-CD3 (1μg/ml; clone-145-2C11) and anti-CD28 (5μg/ml; clone-37.51) antibodies (Biolegend) for 3 days ...
-
bioRxiv - Cancer Biology 2022Quote: ... and activated with plate-bound anti-CD3 (1μg/ml; clone-145-2C11) and anti-CD28 (5μg/ml; clone-37.51) antibodies (Biolegend). For suppressing proliferation ...
-
bioRxiv - Immunology 2023Quote: ... T cell proliferation was stimulated with anti-CD3ε (1 μg/mL)/CD28 (1 μg/mL) antibodies (BioLegend). The anti-CD3ε antibody was coated on each well of the plate via overnight incubation at 4°C with PBS before coculture ...
-
bioRxiv - Genomics 2024Quote: ... at a 1:300 dilution with DAPI 2 μl in 1 ml of 10 μg/ml (BioLegend) and kept on light rotation for 2 h at RT ...
-
bioRxiv - Immunology 2024Quote: ... 1 mL 50 mg/mL PE/Dazzle594-mouse-anti-human CD16 (BioLegend; Cat. No. 302054; clone 3G8), 1 mL 100 mg/mL PE/Cy7-mouse-anti-human CD39 (BioLegend ...
-
bioRxiv - Immunology 2024Quote: ... 0.5 mL 200 mg/mL APC/Cy7-mouse-anti-human CD3 (BioLegend; Cat. No. 317342; clone OKT3), 2 mL 200 mg/mL BV711-mouse-anti-human CD49a (BD Biosciences ...
-
bioRxiv - Immunology 2020Quote: ... cells were re-stimulated with plate-bound CD3 and soluble CD28 antibodies with the presence of 20 ng/μl IL-2 (Biolegend #589106) for 3 days before infection with HIV-1 reporter viruses ...
-
bioRxiv - Neuroscience 2021Quote: ... slices were incubated overnight at 4°C in 1X PBS with 1% NGS and 0.1% Triton-X with primary antibodies against Synaptophysin (1:1000, #837101, BioLegend, CA, USA), PSD95 (1:500 ...
-
bioRxiv - Cancer Biology 2023Quote: IGSF3-Fc or normal human IgG (250 ng) and APC-conjugated anti-human IgG-Fc antibody (BioLegend, San Diego, CA, USA) was added to 1 × 105 of MS1 cells suspended in 100 µL of FACS buffer (0.5% BSA/HBSS ...
-
bioRxiv - Synthetic Biology 2021Quote: ... non-tissue culture treated plates were coated with 2μg/ml anti-CD3 clone OKT3 (NCI Preclinical Repository) with or without 2μg/ml anti-CD28 clone CD28.2 (BioLegend) by incubating at 4°C overnight ...
-
bioRxiv - Cell Biology 2020Quote: ... mouse anti-Vimentin (Santa-Cruz; 2 μg/mL) and mouse anti-placental alkaline phosphatase (Biolegend; 1 μg/mL). Immunostaining for hCMV was performed as previously described [32] ...
-
bioRxiv - Microbiology 2022Quote: ... washed with 1 mL FACS buffer and incubated with 1 μg mL-1 PE-anti HA.11 (BioLegend) at 4 °C with rocking for 1 h ...
-
bioRxiv - Microbiology 2022Quote: Isolated CD4+T cells from healthy donors were incubated with sE2 or sE2F442NYT in the presence of 5µg/ml human anti-CD3 antibody and 1µg/ml human anti-CD28 antibody (BioLegend) for 2 hrs ...
-
bioRxiv - Systems Biology 2023Quote: ... before permeabilisation and nuclear staining using PBS supplemented with 2ug/mL DAPI (Biolegend, #422801, stock solution 10mg/ml), 5%FBS (Gibco ...
-
bioRxiv - Cancer Biology 2023Quote: ... Sino Biological 10823-R408R; H2Kb-Pac Blue at 0.5 mg/mL, BioLegend 116514; CD45-BV605 at 0.2 mg/mL, BioLegend 103155 ...
-
bioRxiv - Immunology 2023Quote: ... 5×106 splenocytes were added to each well of a 24-well plate and stimulated with anti-CD3 and -CD28 mAb (1μg/ml and 5μg/ml, respectively; Biolegend) for IFN-γ production or LPS (1μg/ml ...
-
bioRxiv - Immunology 2024Quote: ... and 1 mL 400 mg/mL Pacific Blue-mouse-anti-human CD45 (BioLegend; Cat. No. 304029; clone HI30), 1 mL 50 mg/mL PE/Dazzle594-mouse-anti-human CD16 (BioLegend ...
-
bioRxiv - Immunology 2024Quote: ... and 1 mL 70 mg/mL BV421-mouse-anti-human CD103 (Biolegend; Cat. No. 350214; clone Ber-ACT8). After the incubation ...
-
bioRxiv - Neuroscience 2024Quote: ... Sections were then incubated with rat–anti-Ly6G (1.25 μg/mL on-slide, 0.67 μg/mL free-floating, 127602; Biolegend), anti-Iba1 (2 µg/mL on-slide ...
-
bioRxiv - Cancer Biology 2024Quote: ... anti-PD-1 (Bio X Cell, RMP1-14, BE0146, 10 μg/mL or Biolegend, 114102, 10 μg/mL), anti-CD38 (Novus ...
-
bioRxiv - Immunology 2021Quote: ... and 1µg/ml anti-CD49d (9F10, BioLegend). Cells were incubated at 37°C for 5 hours ...
-
bioRxiv - Immunology 2022Quote: ... and 3 μg/ml anti-CD28 (Biolegend) in RPMI with 10% FBS ...
-
bioRxiv - Cell Biology 2022Quote: ... mouse anti-Thy1 (0.5 μg/ml, Biolegend), rabbit anti-Tom20 (1/500 ...
-
bioRxiv - Immunology 2021Quote: ... CD40L (10 ug/ml, Biolegend, Cat#591708), BAFF (20 ng/ml ...
-
bioRxiv - Immunology 2020Quote: ... and 5ul/ml anti-CD28 (BioLegend #102102) for 4 hours at 32°C ...
-
bioRxiv - Immunology 2019Quote: ... anti-CD41-PE (2 μg/ml, HIP8; Biolegend), anti P-selectin-FITC or anti-PSGL1-PE (2.5 and 1.5 μg/ml ...
-
bioRxiv - Immunology 2019Quote: ... 2 μg/ml anti-CD41-PE (HIP8; Biolegend) or one of the following Pacific Blue or Alexa Fluor 488 conjugated antibodies ...
-
bioRxiv - Neuroscience 2021Quote: ... and b-FGF (160μg/ml; 571502, Biolegend). Experiments were conducted after 6 or 14 days of differentiation initiated by growing cells in differentiation media consisting of Advanced DMEM/F12 ...
-
bioRxiv - Microbiology 2020Quote: ... anti-Granzyme B (2µg/ml, GB11; Biolegend), and IL-10 (2µg/ml ...
-
bioRxiv - Microbiology 2020Quote: ... anti-CD11b (1µg/ml, M1/70; Biolegend), anti-CD86 (2µg/ml ...
-
bioRxiv - Microbiology 2020Quote: ... anti-CD86 (2µg/ml, GL-1; Biolegend), anti-Ly6G (1µg/ml ...
-
bioRxiv - Microbiology 2020Quote: ... anti-CD4 (2µg/ml, RM4-4; Biolegend), anti-CD3 (2µg/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 25 mg/ml propidium iodide (Biolegend). After 30 min incubation at room temperature in the dark ...
-
bioRxiv - Cell Biology 2022Quote: ... clone WM-59 (50 µg/mL, BioLegend) and anti-mouse CD31-APC ...
-
bioRxiv - Cell Biology 2022Quote: ... clone MOPC-21 (200 µg/mL, BioLegend); and IgG2a,k-APC ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... and 5 μg/mL Brefeldin A (BioLegend). After 6 h ...
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... and 5 μg/mL Brefeldin A (BioLegend). After 6 h of incubation ...
-
bioRxiv - Immunology 2022Quote: ... αCD28 (1 µg/ml; clone: CD28.2; BioLegend) to the TCR stimulation condition ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 μg/ml anti-FcR (BioLegend, 101319) and 0.2% NaN3 in DPBS ...